Portal vein tumor thrombosis revascularization during sorafenib treatment for hepatocellular carcinoma

Marialuisa Novi; Ernesto C Lauritano; Anna Chiara Piscaglia; Brunella Barbaro; Maria Assunta Zocco; Maurizio Pompili; Antonio Gasbarrini

doi:10.1038/ajg.2009.140

Portal vein tumor thrombosis revascularization during sorafenib treatment for hepatocellular carcinoma

Marialuisa Novi
, Ernesto C Lauritano
, Anna Chiara Piscaglia
, Brunella Barbaro
, Maria Assunta Zocco
, Maurizio Pompili
, Antonio Gasbarrini

Risultato della ricerca: Contributo in rivista › Articolo

23 Citazioni (Scopus)

Abstract

Not available

Lingua originale	Inglese
pagine (da-a)	1852-1854
Numero di pagine	3
Rivista	THE AMERICAN JOURNAL OF GASTROENTEROLOGY
Volume	104
DOI	https://doi.org/10.1038/ajg.2009.140
Stato di pubblicazione	Pubblicato - 2009

Keywords

Angiography
Benzenesulfonates
Carcinoma, Hepatocellular
Dose-Response Relationship, Drug
Drug Administration Schedule
Follow-Up Studies
Humans
Liver Neoplasms
Magnetic Resonance Imaging
Male
Middle Aged
Neoplasm Invasiveness
Neoplastic Cells, Circulating
Portal Vein
Pyridines
Risk Assessment
Treatment Outcome

Accesso al documento

10.1038/ajg.2009.140

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{554555425b2c4d9eabe40b8d2ce2cf43,

title = "Portal vein tumor thrombosis revascularization during sorafenib treatment for hepatocellular carcinoma",

abstract = "Not available",

keywords = "Angiography, Benzenesulfonates, Carcinoma, Hepatocellular, Dose-Response Relationship, Drug, Drug Administration Schedule, Follow-Up Studies, Humans, Liver Neoplasms, Magnetic Resonance Imaging, Male, Middle Aged, Neoplasm Invasiveness, Neoplastic Cells, Circulating, Portal Vein, Pyridines, Risk Assessment, Treatment Outcome, Angiography, Benzenesulfonates, Carcinoma, Hepatocellular, Dose-Response Relationship, Drug, Drug Administration Schedule, Follow-Up Studies, Humans, Liver Neoplasms, Magnetic Resonance Imaging, Male, Middle Aged, Neoplasm Invasiveness, Neoplastic Cells, Circulating, Portal Vein, Pyridines, Risk Assessment, Treatment Outcome",

author = "Marialuisa Novi and Lauritano, \{Ernesto C\} and Piscaglia, \{Anna Chiara\} and Brunella Barbaro and Zocco, \{Maria Assunta\} and Maurizio Pompili and Antonio Gasbarrini",

year = "2009",

doi = "10.1038/ajg.2009.140",

language = "English",

volume = "104",

pages = "1852--1854",

journal = "THE AMERICAN JOURNAL OF GASTROENTEROLOGY",

issn = "0002-9270",

publisher = "New York, NY: Elsevier Science Incorporated -New York: National Gastroenterological Association",

}

TY - JOUR

T1 - Portal vein tumor thrombosis revascularization during sorafenib treatment for hepatocellular carcinoma

AU - Novi, Marialuisa

AU - Lauritano, Ernesto C

AU - Piscaglia, Anna Chiara

AU - Barbaro, Brunella

AU - Zocco, Maria Assunta

AU - Pompili, Maurizio

AU - Gasbarrini, Antonio

PY - 2009

Y1 - 2009

N2 - Not available

AB - Not available

KW - Angiography

KW - Benzenesulfonates

KW - Carcinoma, Hepatocellular

KW - Dose-Response Relationship, Drug

KW - Drug Administration Schedule

KW - Follow-Up Studies

KW - Humans

KW - Liver Neoplasms

KW - Magnetic Resonance Imaging

KW - Male

KW - Middle Aged

KW - Neoplasm Invasiveness

KW - Neoplastic Cells, Circulating

KW - Portal Vein

KW - Pyridines

KW - Risk Assessment

KW - Treatment Outcome

KW - Angiography

KW - Benzenesulfonates

KW - Carcinoma, Hepatocellular

KW - Dose-Response Relationship, Drug

KW - Drug Administration Schedule

KW - Follow-Up Studies

KW - Humans

KW - Liver Neoplasms

KW - Magnetic Resonance Imaging

KW - Male

KW - Middle Aged

KW - Neoplasm Invasiveness

KW - Neoplastic Cells, Circulating

KW - Portal Vein

KW - Pyridines

KW - Risk Assessment

KW - Treatment Outcome

UR - http://hdl.handle.net/10807/12890

U2 - 10.1038/ajg.2009.140

DO - 10.1038/ajg.2009.140

M3 - Article

SN - 0002-9270

VL - 104

SP - 1852

EP - 1854

JO - THE AMERICAN JOURNAL OF GASTROENTEROLOGY

JF - THE AMERICAN JOURNAL OF GASTROENTEROLOGY

ER -

Portal vein tumor thrombosis revascularization during sorafenib treatment for hepatocellular carcinoma

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo